Our Blog

Spheroids as powerul 3D-cell culture intermediates

Spheroids: Why using them and what it is?

spheroids-organ-on-chip-1

Fig 1: Spheroid characteristics. Spheroids show increased biological function and increased cell density in comparison to cell monolayer.

In an organ, a cell needs to be considered together with its whole environment. Each cell is surrounded by a myriad of other cells, either of the same type or not. This entire environment allows cells interactions and contacts in 3 dimensions and also creates physical constraints. The classical culture cell models are for now mainly in 2D, meaning that this environment is far from the 3D environment of a cell located in an organ (other cells, extracellular matrix, interstitium…). There is a need for a 3D model with the advantage of 2D cell lines cultures (easy to do, reproducible, cheap) and approaching the 3 dimensional organization of an organ. The solution is called spheroids. This very interesting solution came out in the 1970s. Spheroids are 3D spherical organoids displaying an increase in cell density and biological functionality in comparison to classical monolayer cell culture. Spheroids are often considered as an intermediate to mimic the level of organization of a tissue/organ.


Spheroids and tumor studies

spheroids-comparison-with-cell-monolayer-and-in-vivo-tumors-2

Fig 2: Key features comparison of cell monolayer, spheroids and in vivo tumor.

Solid tumors are growing in a 3 dimensional architecture and possess a heterogeneous vasculature. This results in a variation of exposure to O2, nutrients, chemical agents… More generally, there is a gradient of diffusion which considerably limits the tumor response to treatments. The generation of tumor spheroids is used as an intermediate model between 2D cell culture and tumor explants culture. Spheroids may contain only one single type of tumor cells, or be more complex by containing multiple cellular types. Cancer researchers may be brought to measure the impact of hypoxia, oxidative stress, cancer cell metabolism, cell migration and invasion, the tumor microenvironment signaling crosstalk and may be involved in the discovery of new anti-cancer drugs. Micro fluidic chips are, for now, probably the best devices to perform such a cancer research.


Spheroids and micro fluidics for new Organ-on-a chip devices

tumor-on-a-chip-3

Fig 3: “Tumor on a chip” represents a vasculature mimicking microfluidic device consisting of PDMS chambers with highly organized microchannels and pneumatic chamber (dark gray) on either sides.

Organs-on-a-chip and more specifically, “tumors-on-a-chip” are revolutionary microengineered biomimetic models. It consists in manufacturing a functional unit of a tumor in a microfluidic device. The device allows the culture of either mono cellular spheroids or the co-culture of tumor cells with other cell types in a relevant architecture that replicates the tumor microenvironment. The microfluidic device integrates a chamber allowing the attachment of the spheroids, the perfusion of the culture medium with or without a dissolved chemical.

In addition, Cherry Biotech implemented its cutting-edge microfluidic temperature controller to this spheroid-on-a-chip development. This is the “SpOC” project where Cherry R&D team aims at mimicking the 3D-cellular microenvironment of an in vivo model using spheroids. The chip is composed of an inert plastic polymer, channels, and may integrate a porous membrane for advanced medium perfusion. The tumor spheroid grows in the chamber and the metastatic cells are carried away by the medium flow and might be detected afterward. Custom microfabrication of the chip and real-time data recording are some of the advantages of this technique. Real time optical microscopy is a useful tool to follow the spheroid geometry and measure the impact of a chemical on it. Moreover, the “spheroïd-on-a-chip” model provides new avenues for genomic and drug screenings, in addition to the detection of circulating tumor cells (CTC).

Bibliography/Sources

Figure 1: https://www.bioscience.org/2013/v5e/af/E594/fulltext.php?bframe=figures.htm

Nath, G.R. Devi / Pharmacology & Therapeutics 163 (2016) 94–108

Written by Pierre Gaudriault

Written by Pierre Gaudriault

Innovation Unit | Intrapreneur

Pierre is incubated in our Entrepreneurship school. LEARN MORE.
Tags: ,

This is a unique website which will require a more modern browser to work! Please upgrade today!

Social Media Auto Publish Powered By : XYZScripts.com